Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-008501
Filing Date
2025-01-23
Accepted
2025-01-23 21:21:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 11246
2 EX-1 ck0001669811-ex1.pdf EX-1 292689
  Complete submission text file 0000950170-25-008501.txt   416420
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Subject) CIK: 0001820190 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91963 | Film No.: 25551441
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 650-516-4310
SCLX Stock Acquisition JV LLC (Filed by) CIK: 0001994894 (see all company filings)

IRS No.: 933031787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A